𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats

✍ Scribed by Akos Heinemann; Christof H Wachter; Peter Holzer; Peter Fickert; Rudolf E Stauber

Book ID
110003007
Publisher
Nature Publishing Group
Year
1997
Tongue
English
Weight
325 KB
Volume
121
Category
Article
ISSN
0007-1188

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Increased angiogenesis in portal hyperte
Increased angiogenesis in portal hypertensive rats: Role of nitric oxide
✍ Lazar T. Sumanovski; Edouard Battegay; Michael Stumm; Maaike van der Kooij; Corn πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 560 KB

Systemic and especially splanchnic arterial vasodilation accompany chronic portal hypertension. Different soluble mediators causing this vasodilation have been proposed, the strongest evidence being for nitric oxide (NO). No data exist if structural vascular changes may partly account for this vasod

Enhanced release of nitric oxide in resp
Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats
✍ Naoki Hori; Reiner Wiest; Roberto J. Groszmann πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 159 KB πŸ‘ 1 views

Increased nitric oxide (NO) release has been implicated in the pathogenesis of the hyperdynamic circulation in portal hypertension. NOS 3 (eNOS) causes NO release from the endothelium in response to physical stimuli, such as increased blood flow and shear stress. We evaluated the functional activity

The role of nitric oxide in the vascular
The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats
✍ Fa-Yauh Lee; Agustin Albillos; Luis A. Colombato; Roberto J. Groszmann πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 607 KB

This study examined whether an increased activity of the endothelium-derived relaxing factor, nitric oxide, may account for the hyporesponsiveness to vasoconstrictors in portal hypertension. W e performed dose-response curves to methoxamine, an eadrenoceptor agonist, with and without N"dtr0-Larginin